Reuters logo
BRIEF-Diamyd Medical ‍files preliminary patent application for drug Remygen​
September 27, 2017 / 6:22 AM / in a month

BRIEF-Diamyd Medical ‍files preliminary patent application for drug Remygen​

Sept 27 (Reuters) - DIAMYD MEDICAL AB

* ‍FILED A PRELIMINARY PATENT APPLICATION ON FORMULATION AND RELEASE CHARACTERISTICS OF GABA-BASED STUDY DRUG REMYGEN​

* ‍WILL NOW COMMENCE DESIGNING FIRST CLINICAL TRIAL BASED ON REMYGEN AND DEFINING LONG-TERM DRUG DEVELOPMENT STRATEGY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below